ファイザーは、金融会社が保有株を削減したにもかかわらず、好調な収益を報告し、予想を引き上げました。 Pfizer reports strong earnings and raises forecast, despite financial firms reducing holdings.

財務顧問は,PFECの保有を削減したが,同社は強い収益を報告し,その収益予測を上げた. Financial advisory firms have reduced their holdings in Pfizer Inc., but the company reported strong earnings and raised its earnings forecast. 7%の配当収率とP/eの比率が低いため,PFizerは,配当所得に関心を持つ投資家にとって,良い買い手とみなす. With a 7% dividend yield and a low P/E ratio, Pfizer is seen as a good buy for investors interested in dividend income. 同社はまた,2027年までに相当な費用の節約を図り,財政の展望を高めている. The company is also on track to deliver significant cost savings by 2027, boosting its financial outlook.